Phase 2 trial of Oxford Covid vaccine to begin today
The observer-blind, randomised controlled study to determine the safety and immunogenicity of "Covishield" on healthy Indian adults will begin at Bharati Vidyapeeth Medical College and Hospital in Pune.
No comments:
Post a Comment